Fever with rash following zolendronic acid administration [4]

Clinical and Experimental Rheumatology

Volumn 24, Issue 4, 2006, Pages 455-

  Rizos, E C ^a   Milionis, H J ^a   Elisaf, Moses S ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; FOLIC ACID; LORATADINE; METHOTREXATE; PREDNISONE; VITAMIN D; ZOLEDRONIC ACID;

ADULT; CASE REPORT; CLINICAL EXAMINATION; DRUG ERUPTION; EOSINOPHIL COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; LETTER; LEUKOCYTE COUNT; MACULOPAPULAR RASH; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; ANTIPRURITICS; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; EXANTHEMA; FEMALE; FEVER; GLUCOCORTICOIDS; HUMANS; IMIDAZOLES; INJECTIONS, INTRAVENOUS; LORATADINE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PREDNISONE; TREATMENT OUTCOME;

EID: 33748543921     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. PERRY CM, FIGGIT DP: Zolendronic acid: a review of its use in patients with advanced cancer. Drugs 2004; 64: 1197-211.
2. ZOJER N, KECK AV, PECHERSTORFER M: Comparative tolerability of drug therapies for hypercalcaemia of malignancy. Drug Saf 1999; 21: 389-406.
3. CASCINU S, CASADEI V, DEL FERRO E, ALESSANDRONI P, CATALANO G: Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy. Support Care Cancer 1996; 4: 31-3.
4. PAJUS I, LESTANG P, LIOTE F, DRYLL A: Erythroderma after clodronate treatment. BMJ 1993; 307: 484.
5. WHITNEY AH, COHEN JB, WETHERINGTON W, COCKERELL CJ: Superficial gyrate erytherna as a cutaneous reaction to alendronate for osteoporosis. J Am Acad Dermatol 2003; 48: 945-6.
6. BISWAS PN, WILTON LV, SHAKIR SAW: Pharmacovigilance study of alendronate in England. Osteoporos Int 2003; 14: 507-14.
7. ELLIOTT AT, MURRAY T, MACKIE RM, HUNTER JA: Severe reaction to diphosphonate: implications for treatment of Pajet's disease. BMJ 1988; 297: 592-3.
8. COAKLEY G, ISENBERG DA: Toxic epidermal necrolysis, pancytopenia and adult respiratory syndrome. Br J Rheumatol 1995: 34: 798.
9. ROUX C, LISTRAT V, VILLETTE B et al.: Long-lasting dermatological lesions after tiludronate therapy. Calcif Tissue Int 1992; 50: 378-80.